These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9311723)

  • 21. Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms.
    Knechtle SJ; Wang J; Graeb C; Zhai Y; Hong X; Fechner JH; Geissler EK
    J Immunol; 1997 Jul; 159(1):152-8. PubMed ID: 9200450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
    Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients.
    Graeb C; Justl M; Scherer MN; Andrassy J; Frank E; Zuelke C; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):844-52. PubMed ID: 12368036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation.
    Tu Y; Arima T; Flye MW
    Transplantation; 1997 Jan; 63(2):177-81. PubMed ID: 9020314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival of orthotopic Lewis liver grafts in Wistar Furth rats. Elimination or inactivation of effector CTL and altered antigenicity as possible reasons for tolerance.
    Yamaguchi J; Kanematsu T; Shiku H; Nakayama E
    Transplantation; 1994 Feb; 57(3):412-8. PubMed ID: 8108877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.
    Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ
    Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
    Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
    Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.